Nrf2 Activators as Attractive Therapeutics for Diabetic Nephropathy

por de Haan, Judy B.
Publicado 2011

The ethical dimension in published animal research in critical care: the dark side of our moon

por Huet, Olivier, de Haan, Judy B
Publicado 2014

Targeting Endothelial Dysfunction in Vascular Complications Associated with Diabetes

por Sharma, Arpeeta, Bernatchez, Pascal N., de Haan, Judy B.
Publicado 2012

Targeting Oxidative Stress in Diabetic Complications: New Insights

por Wu, Hao, Cai, Lu, de Haan, Judy B., Giacconi, Robertina
Publicado 2018

Dimethyl Fumarate and Its Esters: A Drug with Broad Clinical Utility?

por Kourakis, Stephanie, Timpani, Cara A., de Haan, Judy B., Gueven, Nuri, Fischer, Dirk, Rybalka, Emma
Publicado 2020

Targeting Nrf2 for the treatment of Duchenne Muscular Dystrophy

por Kourakis, Stephanie, Timpani, Cara A., de Haan, Judy B., Gueven, Nuri, Fischer, Dirk, Rybalka, Emma
Publicado 2020

The Mechanisms of Restenosis and Relevance to Next Generation Stent Design

por Clare, Jessie, Ganly, Justin, Bursill, Christina A., Sumer, Huseyin, Kingshott, Peter, de Haan, Judy B.
Publicado 2022

Oxidative Stress and NLRP3-Inflammasome Activity as Significant Drivers of Diabetic Cardiovascular Complications: Therapeutic Implications

por Sharma, Arpeeta, Tate, Mitchel, Mathew, Geetha, Vince, James E., Ritchie, Rebecca H., de Haan, Judy B.
Publicado 2018

Recent novel approaches to limit oxidative stress and inflammation in diabetic complications

por Pickering, Raelene J, Rosado, Carlos J, Sharma, Arpeeta, Buksh, Shareefa, Tate, Mitchel, de Haan, Judy B
Publicado 2018

An Apolipoprotein A-I Mimetic Peptide Designed with a Reductionist Approach Stimulates Reverse Cholesterol Transport and Reduces Atherosclerosis in Mice

por Ditiatkovski, Michael, D’Souza, Wilissa, Kesani, Rajitha, Chin-Dusting, Jaye, de Haan, Judy B., Remaley, Alan, Sviridov, Dmitri
Publicado 2013

The nuclear factor (erythroid-derived 2)-like 2 (Nrf2) activator dh404 protects against diabetes-induced endothelial dysfunction

por Sharma, Arpeeta, Rizky, Luddwi, Stefanovic, Nada, Tate, Mitchel, Ritchie, Rebecca H., Ward, Keith W., de Haan, Judy B.
Publicado 2017

Ameliorating diabetes-associated atherosclerosis and diabetic nephropathy through modulation of soluble guanylate cyclase

por Sharma, Arpeeta, Choi, Judy, Sim, Lachlan, Dey, Abhiroop, Mohan, Muthukumar, Kantharidis, Phillip, Dietz, Lisa, Sandner, Peter, de Haan, Judy B.
Publicado 2023

The Modified Selenenyl Amide, M-hydroxy Ebselen, Attenuates Diabetic Nephropathy and Diabetes-Associated Atherosclerosis in ApoE/GPx1 Double Knockout Mice

por Tan, Sih Min, Sharma, Arpeeta, Yuen, Derek Y. C., Stefanovic, Nada, Krippner, Guy, Mugesh, Govindasamy, Chai, Zhonglin, de Haan, Judy B.
Publicado 2013

Adverse renal effects of NLRP3 inflammasome inhibition by MCC950 in an interventional model of diabetic kidney disease

por Østergaard, Jakob A., Jha, Jay C., Sharma, Arpeeta, Dai, Aozhi, Choi, Judy S.Y., de Haan, Judy B., Cooper, Mark E., Jandeleit-Dahm, Karin
Publicado 2022

Imatinib inhibits vascular smooth muscle proteoglycan synthesis and reduces LDL binding in vitro and aortic lipid deposition in vivo

por Ballinger, Mandy L, Osman, Narin, Hashimura, Kazuhiko, de Haan, Judy B, Jandeleit-Dahm, Karin, Allen, Terri, Tannock, Lisa R, Rutledge, John C, Little, Peter J
Publicado 2010

Translating atherosclerosis research from bench to bedside: navigating the barriers for effective preclinical drug discovery

por May, Lauren T., Bartolo, Belinda A., Harrison, David G., Guzik, Tomasz, Drummond, Grant R., Figtree, Gemma A., Ritchie, Rebecca H., Rye, Kerry-Anne, de Haan, Judy B.
Publicado 2022

Antiatherosclerotic and Renoprotective Effects of Ebselen in the Diabetic Apolipoprotein E/GPx1-Double Knockout Mouse

por Chew, Phyllis, Yuen, Derek Y.C., Stefanovic, Nada, Pete, Josefa, Coughlan, Melinda T., Jandeleit-Dahm, Karin A., Thomas, Merlin C., Rosenfeldt, Franklin, Cooper, Mark E., de Haan, Judy B.
Publicado 2010

Cardiovascular characterisation of a novel mouse model that combines hypertension and diabetes co-morbidities

por Sharma, Arpeeta, Choi, Judy S. Y., Watson, Anna M. D., Li, Leila, Sonntag, Thomas, Lee, Man K. S., Murphy, Andrew J., De Blasio, Miles, Head, Geoffrey A., Ritchie, Rebecca H., de Haan, Judy B.
Publicado 2023

NFκB Inhibition Mitigates Serum Amyloid A-Induced Pro-Atherogenic Responses in Endothelial Cells and Leukocyte Adhesion and Adverse Changes to Endothelium Function in Isolated Aort...

por Vallejo, Abigail, Chami, Belal, Dennis, Joanne M., Simone, Martin, Ahmad, Gulfam, Abdo, Adrian I., Sharma, Arpeeta, Shihata, Waled A., Martin, Nathan, Chin-Dusting, Jaye P. F., de Haan, Judy B., Witting, Paul K.
Publicado 2018

SOD2 in skeletal muscle: New insights from an inducible deletion model

por Zhuang, Aowen, Yang, Christine, Liu, Yingying, Tan, Yanie, Bond, Simon T., Walker, Shannen, Sikora, Tim, Laskowski, Adrienne, Sharma, Arpeeta, de Haan, Judy B., Meikle, Peter J., Shimizu, Takahiko, Coughlan, Melinda T., Calkin, Anna C., Drew, Brian G.
Publicado 2021